Stockreport

Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

Portage Biotech Inc.  (PRTG) 
PDF WESTPORT, Conn., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a po [Read more]